Meningitis Vaccine: December 2006 Archives

BioVeris licenses vaccine patent

|

bioveris corpVaccine and medical test maker BioVeris Corp. said Tuesday it licensed a Baxter Healthcare Corp. meningitis vaccine for use in a combination vaccine that would require fewer injections per doctor visit.

Under the deal, BioVeris will receive nonexclusive, worldwide patent rights to the development, testing or use of the Neisseria meningitidis group C vaccine.

BioVeris did not disclose financial terms of the deal, but said it paid a license issue fee and may also make future payments for patent costs, milestone fees related to clinical trials and regulatory approvals.